THE EFFECT OF RETICULOCYTE HEMOGLOBIN CONTENT ON THE DIAGNOSIS OF IRON DEFICIENCY ANEMIA: A META-ANALYSIS STUDY

Abstract

Background: Iron deficiency anemia (IDA) is the most common type of anemia worldwide and has many adverse effects on life quality. This meta-analysis study aims to show that reticulocyte hemoglobin content (CHr) is more effective than routinely used parameters in the diagnosis of IDA. Methods: Comprehensive and systematic research was done using international databases including PubMed, Web of Science, Cochrane Library, Science Direct, and Google Scholar, which contain all articles published on IDA until December 29, 2020. Seventeen articles were included in the meta-analysis. Results: The analyses found the Cohens deffect size (Standardized Mean Difference) values of the parameters. Accordingly, CHr is 2.84 (95\% CI 2.36 to 3.31), mean corpus volume (MCV) is 2.46 (95\% CI 1.97 to 2.95), ferritin is 2.37 (95\% CI 1.63 to 3.11), and transferrin saturation (TSAT) is 3.76 (95\% CI 2.14 to 5.38). To diagnose IDA, the sensitivity value of the CHr concentration was found as 83.5\% (95\% CI 76.1 to 89.8), specificity value to be 91.8\% (95\% CI 85.5 to 96.4), and mean cut-off value as 28.2 pg. Conclusions: The results of our study reveal the findings that CHr is a better biomarker than MCV and ferritin used in determining IDA, and its efficacy is lower than TSAT. It is very important to use it routinely for the pre-diagnosis of IDA, which is very important for public health. The groups in the study are heterogeneous but contain bias. Therefore, meta analyses of studies with less heterogeneity of CHr are needed.